Molecular docking and recent advances in the design and development of cholinesterase inhibitor scaffolds: Coumarin hybrids
Alzheimer is a deadly neurodegenerative disease that commonly attacks elderly people around the world. Therefore, this disease has drawn attention among the researchers to find new potent drugs to treat Alzheimer disease (AD) more efficiently. Coumarin containing scaffold is a potential AD agent. Co...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
Wiley-Blackwell
2019
|
| Subjects: | |
| Online Access: | http://eprints.utm.my/id/eprint/89424/ http://dx.doi.org/10.1002/slct.201903607 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Alzheimer is a deadly neurodegenerative disease that commonly attacks elderly people around the world. Therefore, this disease has drawn attention among the researchers to find new potent drugs to treat Alzheimer disease (AD) more efficiently. Coumarin containing scaffold is a potential AD agent. Coumarin hybrids are frequently used as a template to design novel therapeutic agent for the treatment of AD, which are designed based on using molecular docking. As a result of docking studies shown that coumarin cores can occupy PAS by making extensive hydrophobic interactions with the residues in that region (mainly Trp279, Tyr70, Tyr121, Asp72, Phe290, Trp84, Phe330). The present review compiles research literature on the recent design strategies of coumarin hybrids with anti-Alzheimer's activities and outlined docking studies. |
|---|